Autopsy report · NCT01530256

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)

“The trial was terminated in line with the endpoint committee charter.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 7 years 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

CSL Behring

Sponsor type

Industry

Conditions

Acute GvHD

Interventions

ALD518; ALD518; ALD518

Participants

3

Sites

5

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.